396 related articles for article (PubMed ID: 11986998)
1. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.
Krystal JH; Sanacora G; Blumberg H; Anand A; Charney DS; Marek G; Epperson CN; Goddard A; Mason GF
Mol Psychiatry; 2002; 7 Suppl 1():S71-80. PubMed ID: 11986998
[TBL] [Abstract][Full Text] [Related]
2. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action.
Sanacora G; Saricicek A
CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):127-40. PubMed ID: 17430150
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptors in the control of mood disorders.
Witkin JM; Marek GJ; Johnson BG; Schoepp DD
CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
[TBL] [Abstract][Full Text] [Related]
4. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
Sanacora G; Treccani G; Popoli M
Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
[TBL] [Abstract][Full Text] [Related]
5. GABA function in mood disorders: an update and critical review.
Shiah IS; Yatham LN
Life Sci; 1998; 63(15):1289-303. PubMed ID: 9768867
[TBL] [Abstract][Full Text] [Related]
6. GABA and glutamate systems as therapeutic targets in depression and mood disorders.
Kendell SF; Krystal JH; Sanacora G
Expert Opin Ther Targets; 2005 Feb; 9(1):153-68. PubMed ID: 15757488
[TBL] [Abstract][Full Text] [Related]
7. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.
Li YF
Pharmacol Ther; 2020 Apr; 208():107494. PubMed ID: 31991195
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies implementing glutamate neurotransmission in mood disorders.
Sanacora G; Rothman DL; Mason G; Krystal JH
Ann N Y Acad Sci; 2003 Nov; 1003():292-308. PubMed ID: 14684453
[TBL] [Abstract][Full Text] [Related]
9. The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders.
Ketter TA; Wang PW
J Clin Psychiatry; 2003; 64 Suppl 3():15-20. PubMed ID: 12662129
[TBL] [Abstract][Full Text] [Related]
10. GABAergic dysfunction in mood disorders.
Brambilla P; Perez J; Barale F; Schettini G; Soares JC
Mol Psychiatry; 2003 Aug; 8(8):721-37, 715. PubMed ID: 12888801
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders.
Femenía T; Gómez-Galán M; Lindskog M; Magara S
Brain Res; 2012 Oct; 1476():58-70. PubMed ID: 22541166
[TBL] [Abstract][Full Text] [Related]
12. Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status.
Henter ID; Park LT; Zarate CA
CNS Drugs; 2021 May; 35(5):527-543. PubMed ID: 33904154
[TBL] [Abstract][Full Text] [Related]
13. Novel drugs and therapeutic targets for severe mood disorders.
Mathew SJ; Manji HK; Charney DS
Neuropsychopharmacology; 2008 Aug; 33(9):2080-92. PubMed ID: 18172433
[TBL] [Abstract][Full Text] [Related]
14. A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems.
Wilkinson ST; Sanacora G
Drug Discov Today; 2019 Feb; 24(2):606-615. PubMed ID: 30447328
[TBL] [Abstract][Full Text] [Related]
15. GABA and affective disorders.
Lloyd KG; Morselli PL; Bartholini G
Med Biol; 1987; 65(2-3):159-65. PubMed ID: 2821330
[TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for reduced cortical glutamate-glutamine cycling in rats treated with the antidepressant/antipanic drug phenelzine.
Yang J; Shen J
Neuroscience; 2005; 135(3):927-37. PubMed ID: 16154287
[TBL] [Abstract][Full Text] [Related]
17. [Glutamatergic conception of mood disorders].
Permoda-Osip A; Rybakowski J
Psychiatr Pol; 2011; 45(6):875-88. PubMed ID: 22335130
[TBL] [Abstract][Full Text] [Related]
18. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.
Machado-Vieira R; Salvadore G; Ibrahim LA; Diaz-Granados N; Zarate CA
Curr Pharm Des; 2009; 15(14):1595-611. PubMed ID: 19442176
[TBL] [Abstract][Full Text] [Related]
19. Mood regulation. GABA/glutamate co-release controls habenula output and is modified by antidepressant treatment.
Shabel SJ; Proulx CD; Piriz J; Malinow R
Science; 2014 Sep; 345(6203):1494-8. PubMed ID: 25237099
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets.
Małgorzata P; Paweł K; Iwona ML; Brzostek T; Andrzej P
Expert Opin Ther Targets; 2020 Dec; 24(12):1187-1209. PubMed ID: 33138678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
